ArticleVaccine2020

Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine.

Philip C LaTourette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.